Allient (NASDAQ:ALNT) Raised to "Strong-Buy" at Zacks Research

Key Points

• Zacks Research upgraded Allient from “hold” to “strong-buy.” Wall Street’s overall consensus remains “Moderate Buy,” with an average price target of $82.33.
• Allient reported quarterly EPS of $1.07, beating the $0.74 consensus estimate, and revenue of $164.4 million, above expectations of $155.25 million.
• Analyst views were mixed: JPMorgan cut its price target from $120 to $110 and maintained a “neutral” rating, while Northland Securities raised its earnings forecasts for several future years.

Allient (NASDAQ:ALNT - Get Free Report) was upgraded by research analysts at Zacks Research from a "hold" rating to a "strong-buy" rating in a report issued on Monday, Zacks reports.

Several other equities research analysts have also issued reports on the stock. JPMorgan Chase & Co. reduced their price objective on shares of Allient from $120.00 to $110.00 and set a "neutral" rating for the company in a research note on Friday, November 6th. Weiss Ratings downgraded shares of Allient from a "hold (c+)" rating to a "hold (c)" rating in a research report on Tuesday. Finally, Wall Street Zen raised shares of Allient from a "buy" rating to a "strong-buy" rating in a research report on Saturday. One research analyst has rated the stock with a Strong Buy rating, three have given a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $82.33.

Allient Price Performance

Shares of ALNT opened at $84.63 on Monday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.99 and a current ratio of 3.49. The firm has a market cap of $1.44 billion, a PE ratio of 38.12 and a beta of 1.62. The firm's 50 day moving average price is $98.33 and its 200 day moving average price is $83.12. Allient has a twelve month low of $48.12 and a twelve month high of $121.42.

Allient (NASDAQ:ALNT - Get Free Report) last posted its earnings results on Wednesday, November 4th. The company reported $1.07 EPS for the quarter, topping the consensus estimate of $0.74 by $0.33. Allient had a net margin of 6.24% and a return on equity of 15.80%. The company had revenue of $164.40 million during the quarter, compared to the consensus estimate of $155.25 million. As a group, research analysts expect that Allient will post 2.96 EPS for the current fiscal year.

Institutional Investors Weigh In On Allient

Hedge funds have recently modified their holdings of the business. BlackRock Inc. bought a new position in Allient during the second quarter worth $128,774,000. Jennison Associates LLC boosted its holdings in Allient by 111.5% in the 1st quarter. Jennison Associates LLC now owns 353,430 shares of the company's stock valued at $20,884,000 after purchasing an additional 186,316 shares during the period. Bank of New York Mellon Corp acquired a new stake in Allient in the 2nd quarter worth $9,051,000. Deutsche Bank AG acquired a new stake in Allient in the 2nd quarter worth $6,813,000. Finally, Kornitzer Capital Management Inc. KS increased its holdings in shares of Allient by 16.9% during the 3rd quarter. Kornitzer Capital Management Inc. KS now owns 59,059 shares of the company's stock worth $6,591,000 after purchasing an additional 8,534 shares during the period. 61.57% of the stock is owned by institutional investors.

Allient News Roundup

Here are the key news stories impacting Allient this week:

• Positive Sentiment: Northland Securities raised its earnings forecasts across several periods, including FY2026 EPS to $3.05 from $2.68 and FY2027 EPS to $3.26 from $3.11. It also increased forecasts for FY2028–FY2030, pointing to improved expectations for Allient’s earnings growth. Northland estimates
• Neutral Sentiment: A report said short interest totaled zero shares, which would indicate little reported bearish positioning; however, its description of a “large increase” conflicts with the zero-share figure, making the data difficult to interpret.
• Negative Sentiment: JPMorgan cut its price target to $110 from $120 and kept a neutral rating. The new target still implies upside from the cited $84.63 price, but the reduction may temper sentiment. Report on JPMorgan’s price-target change

Allient Company Profile

Allient Inc. designs and manufactures precision and specialty motion-control and power solutions. Its products include motors, gear motors, motion controllers, drives, encoders, actuators and integrated systems that help equipment move and operate with precision. The company serves a range of markets, including medical, aerospace and defense, industrial automation, robotics, transportation and energy. Allient operates internationally, with customers and operations across North America, Europe and Asia.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.